Digitek

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Digitek

Property Description
Active ingredient Digoxin
Form Tablet, Oral Solution, Injectable Solution
Pharmacological Class Cardiac Glycoside, Positive Inotropic Agent
General Purpose Improving heart pumping efficiency and rhythm control
Origin Derived (Semi-synthetic from Digitalis lanata)

What is Digitek and What Class of Medicine is It?

Digitek is a prescription medication whose active substance is Digoxin, a compound classified primarily as a cardiac glycoside and a positive inotropic agent. As a cardiac glycoside, Digoxin belongs to a small, specific group of cardiotonic compounds that directly influence the force and rhythm of the heart muscle. This classification establishes its core identity, distinguishing the compound from other broad drug classes used in cardiovascular medicine. Digoxin's primary pharmacological class is essential for its role in managing cardiac function, a role clinically recognized across major pharmacological guidelines.

Composition, Origin, and Available Forms

Digoxin, the active ingredient, is a single-ingredient compound characterized as derived, or semi-synthetic, originating historically from the leaves of the Digitalis lanata (woolly foxglove) plant. Digitek is one of the established brand names for this medication, known for supplying the drug in multiple pharmaceutical preparations for administration. It is supplied predominantly as an oral tablet for chronic management, but it is also available as an oral solution and an injectable solution for intravenous delivery. These forms contain Digoxin along with the standard pharmaceutical excipients necessary for stability and delivery.

How Digitek Generally Affects Heart Function

Digitek functions by delivering two essential physiological effects to the heart muscle: it produces a positive inotropic effect by increasing the force of the muscular contraction, and it concurrently produces a negative chronotropic effect by slowing the electrical conduction and overall heart rate. Digoxin is recognized as an essential medicine for cardiovascular conditions, noted for its action in stabilizing heart function and improving circulatory dynamics. This dual effect, aimed at improving both the strength and regularity of the heartbeat, represents its typical use scenario in supporting the circulation of patients with specific chronic heart issues.

Regulatory References

  1. The World Health Organization

What side effects are possible with Digitek?

Possible Side Effects and Safety Information

Digitek (digoxin) possesses a narrow therapeutic index, meaning the effective dose is very close to the dose that can cause toxicity. The safety profile is heavily structured around managing and detecting this toxicity, which primarily affects the heart.


Key Adverse Reactions and Organ Systems

The most frequent adverse events involve three main systems, with overall incidence of reactions ranging from 5% to 20% in clinical data:

System Organ Class Common Adverse Reactions
Cardiac Disorders Slow heart rate, various rhythm changes (arrhythmias)
Gastrointestinal Disorders Anorexia (loss of appetite), nausea, vomiting, diarrhea
Nervous System & Eye Disorders Headache, weakness, dizziness, visual disturbances (e.g., blurred or yellow/green vision)

Serious Adverse Reactions and Safety Constraints

The most serious adverse reactions are potentially fatal cardiac arrhythmias, including ventricular fibrillation and various forms of heart block, which are the main signs of digoxin toxicity. Rarely, intestinal ischemia and hemorrhagic necrosis have been documented.

  • Safety Restrictions: Toxicity risk is significantly increased by pre-existing electrolyte imbalances, such as low potassium (hypokalemia). Renal function must be monitored closely, as the drug is primarily eliminated by the kidneys, and impaired function increases drug levels.
  • Population-Specific Notes: Geriatric patients and those with impaired renal function are at a higher risk for toxicity and require cautious dose selection. In pediatric patients, cardiac arrhythmias are typically the earliest signs of toxicity, differing from the initial GI/CNS symptoms often seen in adults.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information describes Digitek (Digoxin) toxicity as a potentially life-threatening event that primarily affects the cardiovascular system. Manifestations of overdose are often listed as cardiac, gastrointestinal, or neurological.

Documented Overdose Presentations

System Documented Manifestations (as per labeling)
Cardiovascular Cardiac arrhythmias, progressive bradycardia, high-degree Atrioventricular (AV) block, ventricular tachycardia, and ventricular fibrillation.
Gastrointestinal Anorexia (loss of appetite), nausea, vomiting, and diarrhea.
CNS/Sensory Confusion, altered mental status, headache, and visual disturbances, which may include changes in color perception or seeing haloes.

Life-Threatening Outcomes and Required Action

Severe toxicity is associated with critical laboratory findings, specifically hyperkalemia (severely elevated serum potassium concentrations), which is an important predictor of mortality in acute overdose. Life-threatening toxicity is also indicated by severe ventricular arrhythmias and symptomatic high-degree AV block. Immediate medical attention is required for suspected overdose or the onset of severe symptoms.

For the most critical scenarios, the specific antidote, Digoxin Immune Fab, is officially indicated for the reversal of life-threatening toxicity. Management in a medical setting requires continuous cardiac monitoring (EKG) and correction of contributing factors, such as electrolyte imbalances.

Patients with impaired renal function or advanced age are officially noted as being predisposed to an increased risk of chronic toxicity due to slower elimination of the compound.

Therapeutic Uses of Digitek

What Digitek treats: main uses and benefits

The primary use of Digitek (Digoxin) is associated with the symptomatic management of chronic heart failure and the control of the heart rate in certain atrial arrhythmias. Its application is relevant for heart failure in adults and for controlling the resting ventricular rate in chronic atrial fibrillation.

Supporting Symptom Management in Heart Conditions

Digitek is commonly considered in the management of symptoms related to chronic heart failure, particularly when the heart's pumping action is weakened. It helps address associated symptoms that may become intense or disruptive, such as breathlessness, fatigue, and palpitations.

It is relevant in therapeutic contexts involving supportive control over a rapid heart rate in conditions like atrial fibrillation and atrial flutter. This assists with symptom stabilization and supports general well-being during symptomatic periods by helping to ease the overall symptom burden.


Quick Fact: Support for Fluid Accumulation

Digitek is generally considered relevant in conditions characterized by fluid overload. It helps address symptoms related to physical discomfort, such as edema (swelling), by supporting improved systemic circulation.

Eligibility and Restrictions for Use

Digitek (digoxin) is authorized for use in Adults and Pediatric Patients. However, regulatory documents establish strict contraindications and require significant caution in specific populations due to the narrow therapeutic index of the medicine.

Contraindications

Use is prohibited for patients with:

  • Ventricular Fibrillation
  • Known Hypersensitivity to digoxin or any digitalis preparation
  • Arrhythmias caused by prior cardiac glycoside intoxication
  • Accessory Atrioventricular (AV) Pathway (e.g., Wolff-Parkinson-White syndrome) who develop atrial fibrillation, due to risk of rapid ventricular response.

Restricted Use and Special Populations

Eligibility is limited or requires special consideration and monitoring for the following groups:

Population/Condition Restriction Basis
Impaired Renal Function Requires mandatory dosage adjustment; primary route of elimination.
Electrolyte Imbalances Toxicity risk is increased by Hypokalemia, Hypomagnesemia, or Hypercalcemia; these must be corrected.
Older Adults (Geriatric) Require careful dose selection due to potential for age-related decline in kidney function.
Pregnancy/Lactation Use during pregnancy is allowed only if the benefit is clearly justified. The drug passes into breast milk but is considered minimal risk for the infant.

Use is generally not recommended in conditions like Acute Myocardial Infarction or Myocarditis.

What should I know about interactions with other medicines?

Digitek (digoxin) has many potential interactions with other prescription and over-the-counter medicines, as well as certain foods and herbal products. These interactions can significantly alter the level of Digitek in the blood, leading to a loss of effectiveness or an increased risk of toxicity. It is crucial to inform your healthcare provider of all current medications and supplements.

Drug Interactions

Many medications can increase Digitek levels, raising the risk of toxicity. These include certain heart rhythm medications (e.g., amiodarone, quinidine, verapamil), some antibiotics (e.g., clarithromycin, erythromycin, tetracycline), and certain blood pressure or cholesterol medications (e.g., carvedilol, atorvastatin).

Other medications can decrease Digitek levels, such as certain antacids, activated charcoal, and the antibiotic rifampicin. Medications that cause a loss of potassium or magnesium (like some diuretics) can also increase the risk of Digitek toxicity.

Food and Herbal Interactions

Type Examples Effect
Herbal Supplements St. John's Wort May decrease Digitek's effectiveness.
Licorice, Horsetail May lower potassium, increasing toxicity risk.
Dietary Products High-bran fiber foods (e.g., oatmeal) May decrease the absorption of Digitek.

Always consult a pharmacist before taking any new medicine, including herbal remedies, vitamins, or supplements, while on Digitek therapy.

Mechanism of Action

Positive Inotropy via Direct Cellular Enzyme Inhibition

The primary action of Digoxin involves the reversible inhibition of the myocardial Sodium-Potassium ATPase ( Na^+/ K^+ ATPase) pump . This molecular step initiates a cascade that leads to an increased availability of intracellular calcium ( Ca^2+) near the muscle fibers. The resulting enhanced calcium binding to the contractile proteins produces a positive inotropic effect, which is an intrinsic increase in the force and velocity of the heart muscle contraction.

Nodal Activity Modulation Through Autonomic Vagal Enhancement

Digoxin engages a secondary mechanism by enhancing parasympathetic (vagal) efferent activity on the heart's conduction system. This neurogenic modulation slows the inherent automaticity of the Sinoatrial (SA) node and decreases the speed of electrical impulse transmission through the Atrioventricular (AV) node. This dual action results in a negative chronotropic effect (slower rate) and a negative dromotropic effect (slower conduction velocity).

Mechanistic Constraints by Ion Flux and Adrenergic State

The strength of the molecular interaction is physiologically constrained by the surrounding ion environment; for instance, low potassium ( K^+) levels increase the binding affinity of the drug to the Na^+/ K^+ ATPase pump. Furthermore, the effect of vagal enhancement on nodal activity is subject to being overridden by high sympathetic (adrenergic) drive.

Dosage and Administration Information

The administration of Digitek (digoxin) must strictly follow the individualized regimen prescribed by a physician, as therapeutic and toxic levels of the medicine are narrowly separated. The oral formulations (tablets, capsules, or elixir) are typically taken once daily, at the same time each day, to maintain consistent concentration in the blood.

Administration and Dosing Rules

Administration Scope General Requirements
Route & Form Oral; Tablets/Capsules must be swallowed whole. Liquid forms (elixir) must be measured using only the calibrated dropper/syringe provided.
Dosing Schedule Individualized and adjusted based on factors like age, body weight, and kidney function. Do not change the dose or stop the medicine without medical consultation.
Timing & Meals May be taken with or without food. Taking with high-fiber meals may reduce absorption.

Missed Dose and Monitoring

If a dose is missed, take it as soon as you remember. However, if it is less than 12 hours until the next scheduled dose, skip the missed one and continue the regular schedule. Do not take a double dose to make up for a missed dose. Regular medical follow-up is required, often involving blood tests, to monitor the concentration of the medicine in the blood to assess its effect and guide any necessary dose adjustments.

Recent Clinical Evidence

Digitek: Recent Clinical Evidence


Overview of the Context and Efficacy Studies

Studies have examined the use of the compound (digoxin) in the context of specific heart conditions, to explore its potential effects on pain and inflammation. Research has investigated whether this approach is associated with a reduction in symptoms in certain patient populations. Clinical trials have assessed the impact of the compound on patient-reported quality of life measures.

Key Findings from Clinical Trials

Heart Failure and Atrial Fibrillation

The Digitalis Investigation Group (DIG) trial, a major study, evaluated the compound’s safety and efficacy profile in adults with heart failure. The primary findings suggested that the use of digoxin was associated with a significant reduction in heart failure-related hospitalizations, while having no effect on overall mortality.

Long-term Data and Monitoring

Trials lasting up to six months have tracked the patient experience over time. Analysis of the long-term data points showed that initial changes were observed, and researchers continue to evaluate the durability of these findings. Studies examining use beyond six months remain ongoing to provide a more complete picture of extended application.

Studies on Patient Demographics and Safety Profile

The studies included adult populations across various age ranges. The safety profile was assessed by tracking the incidence and severity of adverse events across all treatment groups. Common adverse reactions reported across trials included gastrointestinal disturbances (such as nausea and vomiting) and cardiac rhythm changes, particularly when blood levels were above the therapeutic range. A sub-group analysis of participants with pre-existing conditions was conducted to evaluate findings in individuals with severe kidney impairment.

Key Studies & References

  1. The Effect of Digoxin on Mortality and Morbidity in Patients with Chronic Heart Failure (The Digitalis Investigation Group (DIG) Trial)
  2. Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis
  3. Chronic heart failure in adults: diagnosis and management (NICE Guideline NG106)

Frequently Asked Questions (FAQ)

Common questions about Digitek (FAQ)

Q: If I miss a dose of Digitek, what is the general guidance on what to do?

If a dose of this medication is missed, official patient information advises omitting the forgotten dose entirely. The recommended approach is to continue with the usual schedule and take the next dose at the regular time. Regulatory instructions state that two doses should not be taken at once to compensate for a missed dose.

Q: Can Digitek be taken with food, or does it need to be taken on an empty stomach?

The tablets may generally be taken either with or without food. However, official labeling for the compound indicates that taking the medicine alongside meals that are high in bran fiber may result in a reduction of the amount of the drug absorbed by the body.

Q: Can Digitek be crushed or chewed if someone has trouble swallowing pills?

Official guidance for the oral tablets and capsules specifies that they must be swallowed whole. If there are difficulties in swallowing, medication handling guidelines indicate that the liquid oral solution may be an alternative formulation. Any decision regarding alternative administration methods is a clinical matter.

Q: Can drinking alcohol affect how Digitek works?

Official regulatory-cited information notes a Minor level interaction with alcohol. As a general rule for this medication, consultation with a healthcare provider is noted regarding the consumption of alcohol while on therapy, due to the potential for interactions.

Q: Why is the dosage of Digitek so different for different people?

Dosage must be individualized because the range between an effective dose and a dose that may cause toxicity is very narrow. Regulatory documents state that dosing is determined based on patient-specific factors, including their age, lean body weight, and renal (kidney) function, which all affect how the body processes the drug.

Q: What happens if a pregnant person takes Digitek?

Use during pregnancy is allowed only if the potential benefit to the patient is clearly justified. The condition for which the drug is indicated requires professional management, and a physician may monitor drug levels in the blood more closely to manage potential risks.

Q: What information is available about Digitek and breastfeeding?

Official patient information notes that the compound passes into breast milk in very small amounts and has not been known to cause side effects in breastfed infants. The available information suggests it is generally compatible with breastfeeding, as determined by a healthcare provider.

Q: How quickly should Digitek start working after the first dose?

The time required to achieve a measurable pharmacologic effect following oral tablet administration is generally reported to be between 0.5 to 2 hours. The peak effect, when the drug reaches its highest influence, typically occurs between 2 to 6 hours after the first dose.

Q: Are there any specific vitamins or supplements that interact with Digitek?

While some herbal supplements (like St. John's Wort) are specifically named in interaction warnings, information on interactions with common vitamins is generally not available on product labeling. Official guidance emphasizes the importance of informing a doctor or pharmacist about all vitamins and supplements being taken, as they may not be fully evaluated for interactions.

Q: Does Digitek stay in your system for a long time after you stop taking it?

The medication has a relatively long elimination half-life, which is the time it takes for half the drug to be eliminated from the body. In individuals with normal kidney function, the half-life is approximately 1.5 to 2.0 days. This indicates the drug can take several days to be fully cleared from the system.

Q: Is Digitek approved for use in children?

Yes, the compound is indicated for use in pediatric patients. Specifically, it is used to increase the heart's muscle contraction force in children diagnosed with heart failure. Dosage for this population requires careful selection and monitoring due to the toxicity risk.

Q: Is Digitek appropriate for older adults (seniors)?

Official information states that geriatric patients require careful selection of dose and close monitoring for side effects. This is primarily due to the potential for age-related decline in kidney function, which puts them at a higher risk for toxicity.

Q: Are there any recent research findings about Digitek I should know about?

The clinical evidence base for the compound is subject to periodic review and re-evaluation to ensure its continued appropriate use and safety profile. Official regulatory labeling is updated over time to reflect the analysis of ongoing and accumulated clinical data.

Q: Can I take Digitek if I also take a medication for high blood pressure?

The drug has the potential to interact with many other medications, including certain medications used to treat high blood pressure. These interactions may alter drug levels in the blood. The potential effects of co-administration are clinically considered by a healthcare professional before and during therapy.

Q: Is it necessary to have routine blood tests while taking Digitek?

Yes, regulatory documents indicate that regular medical follow-up is required, and this often involves blood tests. These tests specifically monitor the concentration of the medicine in the blood, which is essential for determining the effects and guiding any necessary dose adjustments.

Q: What are the signs of a serious side effect from Digitek?

Early, non-specific signs of toxicity may initially present as lethargy, confusion, appetite loss, or stomach upset. The most serious adverse events are potentially fatal changes in heart rhythm, which requires the attention of a healthcare professional.

Q: Why does the label warn about grapefruit juice and Digitek?

Studies have examined this interaction and found that grapefruit juice can lead to modest changes in the way the body processes the compound in the blood. This effect is thought to be related to the juice's influence on the absorption of the drug in the intestine.

Q: Can Digitek cause mental fog or confusion?

Official product information describes a confusional state as a non-specific clinical feature that is associated with drug toxicity. Furthermore, confusion, apathy, and psychotic disorders have been reported, although these are listed as very rare psychiatric adverse reactions.

Q: If I'm planning surgery, do I need to stop taking Digitek beforehand?

General perioperative guidance suggests that the medication is typically continued during surgical procedures to avoid the risk of heart condition exacerbation. Any decision regarding temporary dose changes or interruption prior to surgery is a complex clinical matter managed by the surgical and medical team.

Q: Does Digitek cause people to gain or lose weight?

Weight changes are not listed as common side effects of the medication. However, certain adverse event reports have documented weight loss in older adults and failure to thrive in infants in situations associated with toxicity or overdose.

Q: Can Digitek cause vivid dreams or sleep disturbances?

Adverse events have been reported involving the Nervous System, including headache and dizziness. While vivid dreams are not specifically listed, other Central Nervous System disturbances, such as drowsiness and behavioral disturbances, have been noted in the context of adverse events or overdose.

Q: Does Digitek help with all types of irregular heartbeats?

According to official indications, the drug is used for the control of resting heart rate in patients with chronic atrial fibrillation. It is also indicated for the management of certain other supraventricular arrhythmias, meaning it is used for specific types of irregular heartbeats, not all types.

Q: Is it common to have nausea or stomach upset when starting Digitek?

Gastrointestinal issues, including nausea and vomiting, are listed in clinical trial data as Common adverse reactions. These symptoms are also clinical features associated with drug toxicity, which necessitates clinical assessment.

How should Digitek be stored and disposed of?

Storage Requirements

Digitek (digoxin tablets) must be stored at controlled room temperature, typically below 25 C (77F), as required by official labeling. The medication must be kept in the original, tightly closed container and stored away from excess heat, moisture, and direct light. The regulatory labeling explicitly states that the medicine must be kept out of the sight and reach of children.

Stability and Handling

Product Form Stability Constraint (as labeled)
Oral Solution Use within 15 days after first opening the container.
Oral Solution Do not refrigerate.

Disposal Instructions

Unused or expired Digitek should be disposed of via a community drug take-back program. If a program is unavailable, mix the tablets with an undesirable substance (e.g., dirt) in a sealed bag and discard in the household trash, following established regulatory procedures. Do not flush the product down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Digitek found in:

A-Z Index: